Rituxmab Versus IL-6 in Treating ILD

计划入组 60 人 · 首次发布于 2023 年 7 月 27 日

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

计划入组 600 人 · 首次发布于 2016 年 9 月 2 日

Scleroderma Registry

计划入组 5,000 人 · 首次发布于 2003 年 12 月 17 日

MRTF inhibitors (scleroderma/melanoma)

TBK1 exosite inhibitor (Systemic Lupus Erythematosus/Scleroderma)

Anti-fibrotic (idiopathic pulmonary fibrosis/scleroderma/radiation fibrosis)

Scleroderma Research Foundation

United States

Canadian Scleroderma Research Group

Canada

Scleroderma Autoantibody Types Influence Disease Progression and Clinical Trial Outcomes

Boehringer's Ofev Nears EU Approval for Systemic Sclerosis-Related Lung Disease

ILD Day 2026 Spotlights Precision Medicine's Potential to Transform Interstitial Lung Disease Care